Details of the Drug

General Information of Drug (ID: DM0P2U3)

• Drug Name: AKOS003197197
• Synonyms: CHEMBL3207533; SCHEMBL16922115; AKOS003197197
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 222.63
  Logarithm of the Partition Coefficient (xlogp); 2.1
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 2
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: C8H7ClN6
  IUPAC Name: N-[(E)-(4-chlorophenyl)methylideneamino]-2H-tetrazol-5-amine
  Canonical SMILES: C1=CC(=CC=C1/C=N/NC2=NNN=N2)Cl
  InChI: InChI=1S/C8H7ClN6/c9-7-3-1-6(2-4-7)5-10-11-8-12-14-15-13-8/h1-5H,(H2,11,12,13,14,15)/b10-5+
  InChIKey: SZFUMFNPTAQHAI-BJMVGYQFSA-N
• Cross-matching ID:
  PubChem CID: 9693619
  TTD ID: D06BHM

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cystathionine gamma-lyase (CTH)	TTLQUZS	CGL_HUMAN	Inhibitor	[1]

References

• [1] Cystathionine--lyase (CSE) inhibitors. US9725426.